SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-059031
Filing Date
2024-05-09
Accepted
2024-05-09 06:07:17
Documents
16
Period of Report
2024-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2413941d1_8k.htm   iXBRL 8-K 31860
2 EXHIBIT 99.1 tm2413941d1_ex99-1.htm EX-99.1 70487
7 GRAPHIC tm2413941d1_ex99-1img001.jpg GRAPHIC 5076
  Complete submission text file 0001104659-24-059031.txt   340625

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zura-20240509.xsd EX-101.SCH 3257
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zura-20240509_def.xml EX-101.DEF 26908
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20240509_lab.xml EX-101.LAB 36515
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20240509_pre.xml EX-101.PRE 25532
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2413941d1_8k_htm.xml XML 5582
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 24928359
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)